Y Mabs Therapeutics Inc Asset Turnover Ratio (YMAB), as of second quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Y mabs Therapeutics inc   (NASDAQ: YMAB)
 

Y Mabs Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Y Mabs Therapeutics Inc asset turnover ratio, the ability of Y Mabs Therapeutics Inc 's assets to generate revenue in the second quarter 2025, increased sequentially to 0.73 in the second quarter (Jun 30 2025), yet the ratio remained below the average, as YMAB's position remain challenging.

Within sector 109 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2025 compared to the preceding quarter from 2212 to 2695.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

YMAB Asset Turnover Ratio (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Asset Change -20 % -8.42 % -67.9 % -7.29 % 8.79 %
Y / Y Revenue Change -17.26 % 4.88 % 13.4 % -9.74 % 9.86 %
Asset Turnover Ratio (TTM) 0.73 0.72 0.69 0.45 0.45
YMAB's Total Ranking # 2695 # 2212 # 1490 # 1351 # 2519
Seq. Asset Change 2.33 % -6.02 % 0.29 % -17.05 % 17.14 %
Seq. Revenue Change -9.76 % -21.1 % 43.51 % -19.02 % 14.38 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 110
Healthcare Sector # 375
Overall Market # 2695

Asset Turnover Ratio Statistics
High Average Low
6.81 4.78 3.35
(Dec 31 2022)   (Sep 30 2024)




YMAB Company Profile • Back to YMAB Efficiency Comparisons • Compare YMAB Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2025 Assets at quarter ending Jun 30 2025
Champions Oncology Inc   1.99 $ 56.878  Millions$ 28.566  Millions
Hims and Hers Health Inc   1.97 $ 2,012.312  Millions$ 1,019.773  Millions
P3 Health Partners Inc   1.87 $ 1,461.823  Millions$ 783.052  Millions
Nature s Sunshine Products inc   1.85 $ 459.719  Millions$ 248.441  Millions
Vycor Medical Inc   1.83 $ 1.779  Millions$ 0.973  Millions
Progyny Inc   1.80 $ 1,241.444  Millions$ 689.577  Millions
Quipt Home Medical Corp   1.74 $ 422.961  Millions$ 242.700  Millions
Encision Inc   1.72 $ 6.527  Millions$ 3.796  Millions
International Stem Cell Corporation  1.71 $ 9.201  Millions$ 5.381  Millions
Regen Biopharma Inc   1.69 $ 0.291  Millions$ 0.172  Millions
Marpai Inc  1.65 $ 23.673  Millions$ 14.316  Millions
Cv Sciences Inc   1.62 $ 12.957  Millions$ 8.007  Millions
Privia Health Group Inc   1.60 $ 1,900.071  Millions$ 1,184.357  Millions
Innovage Holding Corp   1.60 $ 853.699  Millions$ 534.720  Millions
Option Care Health Inc   1.59 $ 5,375.352  Millions$ 3,385.202  Millions
Aspira Women s Health inc   1.58 $ 8.634  Millions$ 5.475  Millions
Rockwell Medical inc   1.57 $ 87.415  Millions$ 55.720  Millions
Rigel Pharmaceuticals Inc  1.56 $ 267.921  Millions$ 171.526  Millions
Iridex Corp  1.56 $ 48.646  Millions$ 31.278  Millions
Electrocore Inc   1.49 $ 26.902  Millions$ 18.029  Millions
Talkspace Inc   1.48 $ 201.745  Millions$ 135.985  Millions
Kewaunee Scientific Corporation  1.48 $ 263.299  Millions$ 177.942  Millions
Medinotec Inc   1.47 $ 8.920  Millions$ 6.078  Millions
Adm Tronics Unlimited Inc   1.46 $ 3.313  Millions$ 2.265  Millions
Chemed Corporation  1.46 $ 2,511.915  Millions$ 1,720.593  Millions
Nuo Therapeutics Inc   1.44 $ 1.950  Millions$ 1.354  Millions
Indivior Pharmaceuticals Inc   1.40 $ 2,062.000  Millions$ 1,475.250  Millions
Qhslab Inc   1.40 $ 2.421  Millions$ 1.736  Millions
Koru Medical Systems Inc   1.37 $ 36.848  Millions$ 26.835  Millions
Nephros Inc   1.37 $ 15.573  Millions$ 11.404  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.